Researchers in the U.K. find in a 22-year prospective study of 1134 men, 103 of whom took benzodiazepines regularly for one or more period of the study, that benzodiazepine use was associated with a more than tripled risk of dementia. This effect was observed even after adjustment for psychological distress and other covariables.
Abstract → Gallacher, J., Elwood, P., et. al; Benzodiazepine Use and Risk of Dementia: Evidence from the Caerphilly Prospective Study (CaPS). Journal of Epidemiology & Community Health, 2012; 66:869-893
When will NAMI get the message?
With any other medication, and increased risk like this would result in pulling the products from the market. With antidepressants the risk for death in older patients is substantial. From a blog by paul Andrewa et al. on this site :
“In the study published in the British Medical Journal, antidepressants were estimated to cause 10 to 44 deaths out of a 1000 people over a year, depending on the type of antidepressant. In comparison, the painkiller Vioxx was taken off the market in the face of evidence that it caused 7 cardiac events out of 1000 people over a year. Since cardiac events are not necessarily fatal, the number of deaths estimated to be caused by antidepressants is arguably of much greater concern.” http://www.madinamerica.com/2012/09/things-your-doctor-should-tell-you-about-antidepressants/#comments.
Why is nothing done to forbid marketing of these products?